Leif Anderson
In December 2019 a new type of pneumonia supported by a novel member of the coronoviridae family named SARS-CoV-2 (severe acute respiratory coronavirus 2 syndrome) developed from Wuhan Province in China. A new virus from the family coronoviridae has been detected in Wuhan province, china. Initially the new virus has named as SARS-CoV-2 (severe acute respiratory coronavirus 2 syndrome). The new virus has shared 80% highest nucleotide identity with previous SARS-CoV-1. Symptoms of affected patients with SARS-CoV-2 has characterized by dry cough, fever, dyspnea and fatigue, accompanied by lymphopenia. In most of the severe cases about 10-15% can become more complicated by the onset of interstitial pneumonia with alveolar damage, which may lead to severe Acute Respiratory Distress Syndrome (ARDS) and even death
